person · Reporting owner

Caldwell Jeremy S

Disclosed activity across 1 company

Tapewire entity: 170232
SEC CIK: 0001626854

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ARDELYX, INC.ARDX · Entity 4972	EVP, Chief Scientific Officer	January 16, 2018	January 19, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARDELYX, INC.

Report date January 16, 2018 · Filed January 19, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.10 · Expires 2028-01-16	Direct	117,104	Reported balance After 2018-01-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-01-16 · Grant · Acquired 117,104 · Balance 117,104 F1: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 16, 2018 Filed Jan 19, 2018 00:52 UTC	ARDELYX, INC. ARDX · Entity 4972	GrantStock Option (Right to Buy) · Derivative	117,104	$0.00 Strike: $7.10	$0.00	Disclosure SEC source: 0001140361-18-002464 · doc1.xml · derivative · entry 1 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,104 Underlying: Common Stock · 117,104 shares Expires 2028-01-16 F1 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document
August 09, 2017 Filed Aug 11, 2017 21:05 UTC	ARDELYX, INC. ARDX · Entity 4972	GrantStock Option (Right to Buy) · Derivative	26,512	$0.00 Strike: $4.70	$0.00	Disclosure SEC source: 0001140361-17-031444 · doc1.xml · derivative · entry 2 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,512 Underlying: Common Stock · 26,512 shares Expires 2027-08-09 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest with respect to 2/3 of the shares subject thereto on December 31, 2018 and 1/3 of the shares subject thereto on June 1, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document
August 07, 2017 Filed Aug 11, 2017 21:05 UTC	ARDELYX, INC. ARDX · Entity 4972	GrantCommon Stock	26,512	$0.00	$0.00	Disclosure SEC source: 0001140361-17-031444 · doc1.xml · nonDerivative · entry 1 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,497 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document
March 03, 2017 Filed Mar 4, 2017 00:40 UTC	ARDELYX, INC. ARDX · Entity 4972	SaleCommon Stock	1,026	$14.14	$14,511.85	Disclosure SEC source: 0001140361-17-010644 · doc1.xml · nonDerivative · entry 1 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,985 F1 · shares: Consists of 1,026 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017. F2 · balance_after: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document
January 19, 2017 Filed Jan 24, 2017 01:51 UTC	ARDELYX, INC. ARDX · Entity 4972	GrantStock Option (Right to Buy) · Derivative	106,047	$0.00 Strike: $13.90	$0.00	Disclosure SEC source: 0001140361-17-002603 · doc1.xml · derivative · entry 2 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,047 Underlying: Common Stock · 106,047 shares Expires 2027-01-19 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 19, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document
January 19, 2017 Filed Jan 24, 2017 01:51 UTC	ARDELYX, INC. ARDX · Entity 4972	GrantCommon Stock	17,985	$0.00	$0.00	Disclosure SEC source: 0001140361-17-002603 · doc1.xml · nonDerivative · entry 1 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,985 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document
November 11, 2016 Filed Nov 16, 2016 01:57 UTC	ARDELYX, INC. ARDX · Entity 4972	SaleCommon Stock	2,158	$15.13	$32,645.58	Disclosure SEC source: 0001140361-16-086883 · doc1.xml · nonDerivative · entry 1 Caldwell Jeremy S · CIK 0001626854 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Consists of 2,158 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016 and August 31, 2016. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.